PLAU Antikörper (C-Term)
(1 reference)-
- Target Alle PLAU Antikörper anzeigen
- PLAU (Plasminogen Activator, Urokinase (PLAU))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Ziege
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PLAU Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Produktmerkmale
- Purified IgG
- Aufreinigung
- Purified
- Immunogen
- Peptide with sequence C-HFLPWIRSHTKEEN from the C-terminal of the Urokinase sequence.
- Isotyp
- IgG
- Top Product
- Discover our top product PLAU Primärantikörper
-
anti-Plasminogen Activator, Urokinase (PLAU) (AA 60-90), (N-Term) antibody
PLAU Reaktivität: Human, Maus WB, IHC (p), FACS Wirt: Kaninchen Polyclonal RB04087 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (C-Term) antibodyVerified PLAU Reaktivität: Human ELISA, IHC Wirt: Ziege Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 396-426) antibodyPLAU Reaktivität: Human WB, ELISA, IHC, FACS, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 60-90) antibodyPLAU Reaktivität: Human, Maus WB, ELISA, IHC, FACS Wirt: Kaninchen Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 180-433) antibodyPLAU Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 396-426), (C-Term) antibodyPLAU Reaktivität: Human WB, IHC (p), FACS, IF Wirt: Kaninchen Polyclonal RB04089-04090 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) antibodyPLAU Reaktivität: Human WB, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 16-115) antibodyPLAU Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3B8 unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (C-Term) antibodyPLAU Reaktivität: Human WB, ELISA, IHC (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Plasminogen Activator, Urokinase (PLAU) (AA 17-432) antibodyPLAU Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working dilution should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.5 mg/mL
-
-
: "uPA and uPAR in fibrinolysis, immunity and pathology." in: Trends in immunology, Vol. 25, Issue 8, pp. 450-5, (2004) (PubMed).
-
: "uPA and uPAR in fibrinolysis, immunity and pathology." in: Trends in immunology, Vol. 25, Issue 8, pp. 450-5, (2004) (PubMed).
-
- Target
- PLAU (Plasminogen Activator, Urokinase (PLAU))
- Andere Bezeichnung
- UROKINASE (PLAU Produkte)
- Synonyme
- PLAU antikoerper, u-PA antikoerper, ATF antikoerper, BDPLT5 antikoerper, QPD antikoerper, UPA antikoerper, URK antikoerper, uPA antikoerper, UPAM antikoerper, plasminogen activator, urokinase antikoerper, urokinase-type plasminogen activator antikoerper, PLAU antikoerper, CpipJ_CPIJ002131 antikoerper, CpipJ_CPIJ006543 antikoerper, CpipJ_CPIJ013396 antikoerper, CpipJ_CPIJ013623 antikoerper, Plau antikoerper
- Gen-ID
- 5328
- UniProt
- P00749
- Pathways
- Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Autophagie, Smooth Muscle Cell Migration
-
